ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prostate Specific Antigen (PSA) Biomarker Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-37B877
Home | Market Reports | Health| Nursing
Global Prostate Specific Antigen PSA Biomarker Market Insights Forecast to 2028
BUY CHAPTERS

Global Prostate Specific Antigen (PSA) Biomarker Market Insights, Forecast to 2030

Code: QYRE-Auto-37B877
Report
December 2024
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Siemens Healthcare
DiaSorin
Roche
Tosoh Bioscience
Fujirebio
Boditech
GE Healthcare
Endocare
Quest Diagnostics
Bio Rad Laboratories
Qiagen NV
Myriad RBM

Prostate Specific Antigen (PSA) Biomarker Market

Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis.
Market Analysis and Insights: Global Prostate Specific Antigen (PSA) Biomarker Market
The global Prostate Specific Antigen (PSA) Biomarker market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Prostate Specific Antigen (PSA) Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Prostate Specific Antigen (PSA) Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Prostate Specific Antigen (PSA) Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Prostate Specific Antigen (PSA) Biomarker include Abbott, Siemens Healthcare, DiaSorin, Roche, Tosoh Bioscience, Fujirebio, BodiTech, GE Healthcare and Endocare, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Prostate Specific Antigen (PSA) Biomarker is widely used in various fields, such as Diagnostics, Drug Discovery, Personalized Medicine and Others, etc. Diagnostics provides greatest supports to the Prostate Specific Antigen (PSA) Biomarker industry development. In 2023, global % revenue of Prostate Specific Antigen (PSA) Biomarker went into Diagnostics filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Prostate Specific Antigen (PSA) Biomarker market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Prostate Specific Antigen (PSA) Biomarker, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate Specific Antigen (PSA) Biomarker, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prostate Specific Antigen (PSA) Biomarker revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate Specific Antigen (PSA) Biomarker market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostate Specific Antigen (PSA) Biomarker revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Prostate Specific Antigen (PSA) Biomarker Market Report

Report Metric Details
Report Name Prostate Specific Antigen (PSA) Biomarker Market
Segment by Type
Segment by Application
  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Siemens Healthcare, DiaSorin, Roche, Tosoh Bioscience, Fujirebio, BodiTech, GE Healthcare, Endocare, Quest Diagnostics, Bio-Rad Laboratories, QIAGEN, Myriad RBM
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Prostate Specific Antigen (PSA) Biomarker in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Prostate Specific Antigen (PSA) Biomarker companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Specific Antigen (PSA) Biomarker revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Prostate Specific Antigen (PSA) Biomarker Market report?

Ans: The main players in the Prostate Specific Antigen (PSA) Biomarker Market are Abbott, Siemens Healthcare, DiaSorin, Roche, Tosoh Bioscience, Fujirebio, BodiTech, GE Healthcare, Endocare, Quest Diagnostics, Bio-Rad Laboratories, QIAGEN, Myriad RBM

What are the Application segmentation covered in the Prostate Specific Antigen (PSA) Biomarker Market report?

Ans: The Applications covered in the Prostate Specific Antigen (PSA) Biomarker Market report are Diagnostics, Drug Discovery, Personalized Medicine, Others

What are the Type segmentation covered in the Prostate Specific Antigen (PSA) Biomarker Market report?

Ans: The Types covered in the Prostate Specific Antigen (PSA) Biomarker Market report are Blood, Semen, Urine

Recommended Reports

Prostate Cancer Diagnosis

Cancer Biomarker Testing

Diagnostic Test Kits

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Blood
1.2.3 Semen
1.2.4 Urine
1.3 Market by Application
1.3.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Perspective (2019-2030)
2.2 Global Prostate Specific Antigen (PSA) Biomarker Growth Trends by Region
2.2.1 Prostate Specific Antigen (PSA) Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Prostate Specific Antigen (PSA) Biomarker Market Dynamics
2.3.1 Prostate Specific Antigen (PSA) Biomarker Industry Trends
2.3.2 Prostate Specific Antigen (PSA) Biomarker Market Drivers
2.3.3 Prostate Specific Antigen (PSA) Biomarker Market Challenges
2.3.4 Prostate Specific Antigen (PSA) Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Prostate Specific Antigen (PSA) Biomarker by Players
3.1.1 Global Prostate Specific Antigen (PSA) Biomarker Revenue by Players (2019-2024)
3.1.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Prostate Specific Antigen (PSA) Biomarker, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio
3.4.1 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Biomarker Revenue in 2023
3.5 Global Key Players of Prostate Specific Antigen (PSA) Biomarker Head office and Area Served
3.6 Global Key Players of Prostate Specific Antigen (PSA) Biomarker, Product and Application
3.7 Global Key Players of Prostate Specific Antigen (PSA) Biomarker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Type
4.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2025-2030)
5 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Application
5.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
6.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type
6.2.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2019-2024)
6.2.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2025-2030)
6.2.3 North America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2019-2030)
6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application
6.3.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2019-2024)
6.3.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2025-2030)
6.3.3 North America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2019-2030)
6.4 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country
6.4.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024)
6.4.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
7.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type
7.2.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2019-2024)
7.2.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2025-2030)
7.2.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2019-2030)
7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application
7.3.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2019-2024)
7.3.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2025-2030)
7.3.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2019-2030)
7.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country
7.4.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024)
7.4.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
8.2 China Prostate Specific Antigen (PSA) Biomarker Market Size by Type
8.2.1 China Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2019-2024)
8.2.2 China Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2025-2030)
8.2.3 China Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2019-2030)
8.3 China Prostate Specific Antigen (PSA) Biomarker Market Size by Application
8.3.1 China Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2019-2024)
8.3.2 China Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2025-2030)
8.3.3 China Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
9.2 Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Type
9.2.1 Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2019-2024)
9.2.2 Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2025-2030)
9.2.3 Asia Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2019-2030)
9.3 Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Application
9.3.1 Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2019-2024)
9.3.2 Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2025-2030)
9.3.3 Asia Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2019-2030)
9.4 Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Region
9.4.1 Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2019-2024)
9.4.3 Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type
10.2.1 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application
10.3.1 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country
10.4.1 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Introduction
11.1.4 Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.1.5 Abbott Recent Developments
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Details
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
11.2.4 Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.2.5 Siemens Healthcare Recent Developments
11.3 DiaSorin
11.3.1 DiaSorin Company Details
11.3.2 DiaSorin Business Overview
11.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Introduction
11.3.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.3.5 DiaSorin Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Introduction
11.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.4.5 Roche Recent Developments
11.5 Tosoh Bioscience
11.5.1 Tosoh Bioscience Company Details
11.5.2 Tosoh Bioscience Business Overview
11.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Introduction
11.5.4 Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.5.5 Tosoh Bioscience Recent Developments
11.6 Fujirebio
11.6.1 Fujirebio Company Details
11.6.2 Fujirebio Business Overview
11.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Introduction
11.6.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.6.5 Fujirebio Recent Developments
11.7 BodiTech
11.7.1 BodiTech Company Details
11.7.2 BodiTech Business Overview
11.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Introduction
11.7.4 BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.7.5 BodiTech Recent Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
11.8.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.8.5 GE Healthcare Recent Developments
11.9 Endocare
11.9.1 Endocare Company Details
11.9.2 Endocare Business Overview
11.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Introduction
11.9.4 Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.9.5 Endocare Recent Developments
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Introduction
11.10.4 Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.10.5 Quest Diagnostics Recent Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Introduction
11.11.4 Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Developments
11.12 QIAGEN
11.12.1 QIAGEN Company Details
11.12.2 QIAGEN Business Overview
11.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Introduction
11.12.4 QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.12.5 QIAGEN Recent Developments
11.13 Myriad RBM
11.13.1 Myriad RBM Company Details
11.13.2 Myriad RBM Business Overview
11.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Introduction
11.13.4 Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.13.5 Myriad RBM Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Abbott
Siemens Healthcare
DiaSorin
Roche
Tosoh Bioscience
Fujirebio
Boditech
GE Healthcare
Endocare
Quest Diagnostics
Bio Rad Laboratories
Qiagen NV
Myriad RBM
List of Tables
    Table 1. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Blood
    Table 3. Key Players of Semen
    Table 4. Key Players of Urine
    Table 5. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Region (2019-2024)
    Table 9. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Region (2025-2030)
    Table 11. Prostate Specific Antigen (PSA) Biomarker Market Trends
    Table 12. Prostate Specific Antigen (PSA) Biomarker Market Drivers
    Table 13. Prostate Specific Antigen (PSA) Biomarker Market Challenges
    Table 14. Prostate Specific Antigen (PSA) Biomarker Market Restraints
    Table 15. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Players (2019-2024)
    Table 17. Global Top Prostate Specific Antigen (PSA) Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Biomarker as of 2023)
    Table 18. Global Prostate Specific Antigen (PSA) Biomarker Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Prostate Specific Antigen (PSA) Biomarker Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Prostate Specific Antigen (PSA) Biomarker, Headquarters and Area Served
    Table 21. Global Key Players of Prostate Specific Antigen (PSA) Biomarker, Product and Application
    Table 22. Global Key Players of Prostate Specific Antigen (PSA) Biomarker, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2019-2024)
    Table 26. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2025-2030)
    Table 28. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Application (2019-2024)
    Table 30. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Application (2025-2030)
    Table 32. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Prostate Specific Antigen (PSA) Biomarker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Prostate Specific Antigen (PSA) Biomarker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Prostate Specific Antigen (PSA) Biomarker Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Abbott Company Details
    Table 65. Abbott Business Overview
    Table 66. Abbott Prostate Specific Antigen (PSA) Biomarker Product
    Table 67. Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 68. Abbott Recent Developments
    Table 69. Siemens Healthcare Company Details
    Table 70. Siemens Healthcare Business Overview
    Table 71. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Product
    Table 72. Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 73. Siemens Healthcare Recent Developments
    Table 74. DiaSorin Company Details
    Table 75. DiaSorin Business Overview
    Table 76. DiaSorin Prostate Specific Antigen (PSA) Biomarker Product
    Table 77. DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 78. DiaSorin Recent Developments
    Table 79. Roche Company Details
    Table 80. Roche Business Overview
    Table 81. Roche Prostate Specific Antigen (PSA) Biomarker Product
    Table 82. Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 83. Roche Recent Developments
    Table 84. Tosoh Bioscience Company Details
    Table 85. Tosoh Bioscience Business Overview
    Table 86. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Product
    Table 87. Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 88. Tosoh Bioscience Recent Developments
    Table 89. Fujirebio Company Details
    Table 90. Fujirebio Business Overview
    Table 91. Fujirebio Prostate Specific Antigen (PSA) Biomarker Product
    Table 92. Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 93. Fujirebio Recent Developments
    Table 94. BodiTech Company Details
    Table 95. BodiTech Business Overview
    Table 96. BodiTech Prostate Specific Antigen (PSA) Biomarker Product
    Table 97. BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 98. BodiTech Recent Developments
    Table 99. GE Healthcare Company Details
    Table 100. GE Healthcare Business Overview
    Table 101. GE Healthcare Prostate Specific Antigen (PSA) Biomarker Product
    Table 102. GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 103. GE Healthcare Recent Developments
    Table 104. Endocare Company Details
    Table 105. Endocare Business Overview
    Table 106. Endocare Prostate Specific Antigen (PSA) Biomarker Product
    Table 107. Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 108. Endocare Recent Developments
    Table 109. Quest Diagnostics Company Details
    Table 110. Quest Diagnostics Business Overview
    Table 111. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Product
    Table 112. Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 113. Quest Diagnostics Recent Developments
    Table 114. Bio-Rad Laboratories Company Details
    Table 115. Bio-Rad Laboratories Business Overview
    Table 116. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Product
    Table 117. Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 118. Bio-Rad Laboratories Recent Developments
    Table 119. QIAGEN Company Details
    Table 120. QIAGEN Business Overview
    Table 121. QIAGEN Prostate Specific Antigen (PSA) Biomarker Product
    Table 122. QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 123. QIAGEN Recent Developments
    Table 124. Myriad RBM Company Details
    Table 125. Myriad RBM Business Overview
    Table 126. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Product
    Table 127. Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024) & (US$ Million)
    Table 128. Myriad RBM Recent Developments
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Type: 2023 VS 2030
    Figure 3. Blood Features
    Figure 4. Semen Features
    Figure 5. Urine Features
    Figure 6. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Application: 2023 VS 2030
    Figure 8. Diagnostics Case Studies
    Figure 9. Drug Discovery Case Studies
    Figure 10. Personalized Medicine Case Studies
    Figure 11. Others Case Studies
    Figure 12. Prostate Specific Antigen (PSA) Biomarker Report Years Considered
    Figure 13. Global Prostate Specific Antigen (PSA) Biomarker Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Prostate Specific Antigen (PSA) Biomarker Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Region: 2023 VS 2030
    Figure 16. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Players in 2023
    Figure 17. Global Top Prostate Specific Antigen (PSA) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Biomarker as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Prostate Specific Antigen (PSA) Biomarker Revenue in 2023
    Figure 19. North America Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2019-2030)
    Figure 21. North America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2019-2030)
    Figure 22. North America Prostate Specific Antigen (PSA) Biomarker Market Share by Country (2019-2030)
    Figure 23. United States Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Prostate Specific Antigen (PSA) Biomarker Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2019-2030)
    Figure 27. Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2019-2030)
    Figure 28. Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Country (2019-2030)
    Figure 29. Germany Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Prostate Specific Antigen (PSA) Biomarker Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2019-2030)
    Figure 37. China Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2019-2030)
    Figure 38. Asia Prostate Specific Antigen (PSA) Biomarker Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2019-2030)
    Figure 40. Asia Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2019-2030)
    Figure 41. Asia Prostate Specific Antigen (PSA) Biomarker Market Share by Region (2019-2030)
    Figure 42. Japan Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Country (2019-2030)
    Figure 52. Brazil Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Abbott Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 59. Siemens Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 60. DiaSorin Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 61. Roche Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 62. Tosoh Bioscience Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 63. Fujirebio Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 64. BodiTech Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 65. GE Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 66. Endocare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 67. Quest Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 68. Bio-Rad Laboratories Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 69. QIAGEN Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 70. Myriad RBM Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Prostate Specific Antigen PSA Blood Based Biomarker Market Insights Forecast to 2030
Global One Step Prostate Specific Antigen Test Kit Market Research Report 2024
Global Prostate specific Antigen PSA Testing Market Insights Forecast to 2030
Prostate Specific Antigen PSA Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostate Cancer Test Kit Market Research Report 2025
Global PSA Test Market Insights Forecast to 2030
Global Prostate Specific Antigen PSA Semi Qualitative Kit Market Research Report 2024
Global PSMA Antibody Market Research Report 2024
Global PSA ELISA Test Kit Market Research Report 2024
Global Cancer Antigen Market Research Report 2024
Global Prostate Specific Antigen Market Research Report 2024
Prostate Specific Antigen Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Biomarker Market Insights Forecast to 2030
Global Prostate Cancer Diagnostics Solution Market Research Report 2025
Prostate Specific Antigen Test Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CEA Test Kits Market Research Report 2024
Global Tumor Marker Test Kits Market Research Report 2025
Global Tumor Specific Antigen Market Size Status and Forecast 2019 2025
Global Rapid Prostate Cancer Tests Market Research Report 2024
Protein Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions